Singular Genomics Systems, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Singular Genomics Systems, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Singular Genomics Systems, Inc. Assets for the quarter ending September 30, 2024 was $187M, a 34.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$187M	-$98M	-34.4%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$220M	-$64M	-22.5%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$239M	-$66.4M	-21.7%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$265M	-$62.5M	-19.1%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$285M	-$61M	-17.6%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$284M	-$82.4M	-22.5%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$305M	-$36.6M	-10.7%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$328M	-$27.7M	-7.78%	Dec 31, 2022	10-K	2024-03-18
Q3 2022	$345M	-$25.4M	-6.84%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$366M	-$17.6M	-4.58%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$342M			Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$356M	+$325M	+1066%	Dec 31, 2021	10-K	2023-03-02
Q3 2021	$371M			Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$384M			Jun 30, 2021	10-Q	2021-08-03
Q4 2020	$30.5M			Dec 31, 2020	10-K	2022-03-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.